About two years ago, I was asked to join a Babson College panel discussing the gender gap in venture capital. At the center of the conversation would be the results from the Diana Project, a research study that examined our industry and the stark lack of representation of women investors and funded entrepreneurs. I accepted … Continue reading “The Gap Has Two Sides”
Author: Terry McGuire
As a co-founder and general partner of Polaris Partners, Terry McGuire brings more than 25 years of successful early stage investing experience in healthcare and technology companies.
Prior to starting Polaris in 1996, Terry spent 7 years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago.
As a venture capitalist, Terry has invested in 48 companies. He also co-founded three companies: Inspire Pharmaceuticals (public), AIR (sold to Alkermes) and MicroCHIPS (private). In 2009, Terry was the recipient of the Massachusetts Society for Medical Research Award. In 2005, he received the prestigious Albert Einstein Award for Outstanding Achievement in Life Sciences.
The Road to Predictable Innovation: Genomics in Drug R&D
There is a great need by large biotechs and pharma companies to show true and more predictable innovation. In an industry report issued just last week by Deloitte and Thomson Reuters, analysis of the top 12 pharmaceutical companies globally shows that the risk in new drug discovery have grown worse. The report notes an increasing … Continue reading “The Road to Predictable Innovation: Genomics in Drug R&D”